Replies to post #184360 on Biotech Values

[GrthzGd]

GILD responded quickly:

U.S. Veterans get Sovaldi for $594/pill • 8:43 AM
Douglas W. House, SA News Ed...
It appears that the Veterans Administration and Gilead Sciences (NASDAQ:GILD) have agreed on a price of $594 per dose for its HCV drug Sovaldi (sofosbuvir). This represents a discount of almost 41% from the $1,000 per pill list price.
Earlier this year, the company established a 23% discount to U.S. Government health plans but agreed to extend more substantial discounts to the VA and Department of Defense after facing intense criticism from the medical community and government representatives.
The looming competition from AbbVie (NYSE:ABBV) may have influenced the situation as well